FindTrial
Sign In

Oral probiotics vs standard antimicrobials : In high risk pregnant women with bacterial vaginosis

A Vaginal microbioflora analysis: Effect of supplementation of standard antimicrobial treatment with oral; probiotics on vaginal health of symptomatic high risk pregnant women diagnosed with bacterial vaginosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049462
Enrollment
152
Registered
2023-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O099- Supervision of high risk pregnancy, unspecified

Interventions

None listed

Sponsors

Dr Pooja Adiga
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Symptomatic antenatal women diagnosed to have bacterial and who are at high risk for preterm delivery such as previous H/O spontaneous preterm delivery , h/o preterm prelabor rupture of membranes , h/o chorioamnionitis, h/o second trimester spontaneous abortions Precious pregnancy Women with short cervix Multiple pregnancy Diabetes mellitus in pregnancy

Exclusion criteria

Exclusion criteria: Immunocompromised individuals Those who do not want to be part of the study Women with uterine anomalies

Design outcomes

Primary

MeasureTime frame
To compare the vaginal microbioflora, before and after treatment with oral probiotics along with the standard vaginal antimicrobials, among symptomatic high-risk pregnant women diagnosed to have bacterial vaginosis at 12- 22 weeks of pregnancy.Timepoint: 8 weeks—

Secondary

MeasureTime frame
Comparison of gestational age at delivery, proportion of preterm birthTimepoint: post delivery—

Countries

India

Contacts

Public ContactPooja adiga

KMC MANIPAL

bssujata@gmail.com8660778169

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026